Three tiers. No demo wall.
DrugPatentWatch, PatSnap, IPlytics, GreyB — none of them publish their price. PharmaCliff does. €39 to start, locked for life if you're a founding subscriber.
For the first fifty subscribers.
- Weekly digest, every Tuesday, full archive
- All five jurisdictions, all therapeutic areas
- Subscriber feedback shapes the scoring rubric
- Founding price never increases
- Cap: 50 seats, then closed forever
No card required to read the sample digest first.
For teams who want in before standard pricing lands.
- Weekly digest + full archive
- All jurisdictions, choose up to 4 TA anchors
- Beta-priced through AI-scoring v2 release
- Rolls to standard pricing at GA, not retroactively
Cancel anytime · refund within 30 days.
The price after general availability.
- Weekly digest + full archive + API export
- All jurisdictions, all TA anchors
- Quarterly methodology update calls
- Available from GA — not yet open
GA target: when AI scoring exits beta.
Common pricing questions.
What does the founding tier actually lock?
€39/mo, billed yearly (€468), for the lifetime of your continuous subscription. If standard pricing later rises to €199, you stay at €39. Cancel and re-subscribe and the locked price is gone — that's the only way to lose it.
How do I cancel?
One click via Stripe Customer Portal, or email hello@pharmacliff.com. No retention call. Refund within 30 days of last payment is automatic.
Can I pay by invoice / wire?
Yes for founding tier — pre-Stripe, every reservation is manual and the method is whatever your finance team needs (card, SEPA, wire, PO). Post-Stripe, card is default but invoice / SEPA remain available on request.
Team seats / multiple users?
Founding tier is single-seat by design. Team seats land on standard tier post-GA. Need early team access? Email, there's usually a way.
VAT and invoicing?
EU customers get a proper VAT invoice with reverse-charge for B2B. Non-EU customers get a simple receipt. Operated by a Lithuanian sole proprietorship — Stripe handles the paperwork once live.
More questions? Full FAQ →